The global respiratory devices market is estimated to be valued at USD 23.58 Bn in 2024 and is expected to exhibit a CAGR of 11% during the forecast period (2024-2031). The global respiratory devices market has been witnessing significant growth in the recent years driven by the rising prevalence of respiratory diseases worldwide. Respiratory diseases have become one of the major causes of deaths globally, placing a substantial economic burden on healthcare systems. Various technological advancements in the field of respiratory cadre devices along with increasing investments in research and development of novel respiratory devices by key manufacturers are propelling the market growth. Moreover, growing geriatric population who are more susceptible to respiratory disorders and rising healthcare expenditure in developing nations are some of the key factors likely to contribute to the respiratory devices market during the forecast period. However, certain challenges including lack of awareness about respiratory care in rural areas and high costs associated with advanced respiratory devices may restrain the market growth to a certain extent.

Market Dynamics:

The global respiratory devices market is driven by the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, lung cancer, etc. According to the World Health Organization (WHO), over 385 million people suffer from chronic obstructive pulmonary disease (COPD) worldwide. Additionally, over 235 million people suffer from asthma globally. Growing geriatric population prone to respiratory ailments is another major factor fueling the market growth. The increasing adoption of sedentary lifestyle and growing environmental pollution levels leading to poor air quality have further boosted the incidence rates of respiratory disorders. Various technological advancements in the field of respiratory care devices including development of portable oxygen concentrators, ventilators, nebulizers, and others is a key growth driver. However, high costs associated with advanced respiratory devices especially ventilators and Continuous positive airway pressure (CPAP) machines remain a key challenge. Furthermore, limited availability of advanced respiratory care in rural areas of developing nations restraints the market expansion.

Key Features of the Study:

• This report provides an in-depth analysis of the global respiratory devices market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global respiratory devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this Medtronic, Hamilton Medical, ResMed, Masimo, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., ICU Medical, Inc., Dragerwerk AG & Co. KGaA, TytoCare Ltd., VYAIRE, Medline Industries, Inc., OMRON Corporation, TNI medical AG, and Xplore Health Technologies Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global respiratory devices market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory devices market.

Detailed Segmentation-

• By Product Type:
  • Respiratory Consumables
    • Respiratory Mask
    • Nasal Cannulas
    • Tracheostomy Tubes
    • Other Accessories and Consumables
  • Nebulizers
  • Oxygen Concentrators
  • Positive airway pressure devices
  • Polysomnography Devices
  • Pulse Oximeters
  • Mechanical Ventilators
  • Spirometers
• By Indication:
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Acute Respiratory Infections
  • Others
• By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others 
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Company Profiles:

• Medtronic
• Hamilton Medical
• ResMed
• Masimo
• Teleflex Incorporated
• Fisher & Paykel Healthcare Limited
• Koninklijke Philips N.V.
• ICU Medical, Inc.
• Dragerwerk AG & Co. KGaA
• TytoCare Ltd.
• VYAIRE
• Medline Industries, Inc.
• OMRON Corporation
• TNI medical AG
• Xplore Health Technologies Pvt. Ltd.